Veracyte VCYT Testing revenue — Sample collection expense

Similar metrics at other companies

GRALScreening revenue — Cost of revenue

$21.24M+24.1%

LHDiagnostics — Supplies Expense

$613.5M+4.6%

NTRATest Revenue — Increased revenue

$61M+77.8%

NTRAShipping And Handling — Cost of Goods Sold

$13.68M+25.7%

NTRAProduct revenues — Cost of revenues

$245.2M+32.8%

LHBiopharma Laboratory Services — Supplies Expense

$121.5M+9.4%

Questions, answered.

What is Veracyte's testing revenue — sample collection expense?

Veracyte (VCYT) reported testing revenue — sample collection expense of $3.29M in Q1 2026.

How has Veracyte's testing revenue — sample collection expense changed year-over-year?

Veracyte's testing revenue — sample collection expense increased by 16.4% year-over-year, from $2.83M to $3.29M.

What is the long-term trend for Veracyte's testing revenue — sample collection expense?

Over 3 years (2022 to 2025), Veracyte's testing revenue — sample collection expense has grown at a 8.9% compound annual growth rate (CAGR), from $9.63M to $12.44M.

What does testing revenue — sample collection expense mean?

This includes the costs related to the logistics, kits, and processing required to collect and transport biological samples to the laboratory. It highlights the operational expenses involved in the pre-analytical phase of the diagnostic testing workflow.